Literature DB >> 16925892

The cost of antiretroviral drugs and influence on prescribing policies.

Rachael Jones1, Brian Gazzard.   

Abstract

With the advent of highly active antiretroviral therapy (HAART), the prognosis for HIV-infected individuals with access has been transformed. HAART provides one of the most cost-effective treatments for any chronic disease. Immediate cost remains a legitimate factor when choosing HAART regimens, however, the cost of long-term side-effects and adherence issues must also be considered. The review examines the cost issues associated with HAART prescription and its influence on prescribing policies.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16925892     DOI： 10.1258/095646206778145587

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


  6 in total

1.  Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients.

Authors:  A Buscher; C Hartman; M A Kallen; T P Giordano
Journal:  Int J STD AIDS       Date:  2012-05       Impact factor: 1.359

Review 2.  Novel paradigms for drug discovery: computational multitarget screening.

Authors:  Ekachai Jenwitheesuk; Jeremy A Horst; Kasey L Rivas; Wesley C Van Voorhis; Ram Samudrala
Journal:  Trends Pharmacol Sci       Date:  2008-01-10       Impact factor: 14.819

3.  A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South Africa.

Authors:  Francois van Loggerenberg; Debra Gray; Santhanalakshmi Gengiah; Pinky Kunene; Tanuja N Gengiah; Kogieleum Naidoo; Alison D Grant
Journal:  AIDS Patient Care STDS       Date:  2015-02-18       Impact factor: 5.078

Review 4.  Maraviroc: a review of its use in the management of CCR5-tropic HIV-1 infection.

Authors:  Caroline M Perry
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

5.  Can we talk about price with patients when choosing antiretroviral therapy? A survey with people living with HIV and prescribers in France.

Authors:  Emmanuelle Papot; Nikos Kalampalikis; Marjolaine Doumergue; Fabrice Pilorgé; Guillemette Quatremère; Yazdan Yazdanpanah; Marie Préau
Journal:  BMJ Open       Date:  2021-11-26       Impact factor: 3.006

6.  Individualised motivational counselling to enhance adherence to antiretroviral therapy is not superior to didactic counselling in South African patients: findings of the CAPRISA 058 randomised controlled trial.

Authors:  Francois van Loggerenberg; Alison D Grant; Kogieleum Naidoo; Marita Murrman; Santhanalakshmi Gengiah; Tanuja N Gengiah; Katherine Fielding; Salim S Abdool Karim
Journal:  AIDS Behav       Date:  2015-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.